Literature DB >> 23474852

DBS amplitude setting can improve aspects of quality of life in patients with Parkinson's disease.

Marek Baláž1, Martina Bočková, Ivan Rektor.   

Abstract

The DBS STN is a non-curative treatment; its effect on the patient's quality of life (QoL) determines the therapeutic success of this procedure. We aimed to assess whether stimulation parameters setting may influence also some of the non-motor aspects of QoL. The QoL was assessed by PDQ-39 questionnaire. The questionnaire was administered to patients before and after the DBS surgery. A sham change of stimulation amplitude was performed before the actual increase. After the further amplitude increase in subgroup of patients (mean increase of amplitude of 0.35 V), there was a statistically significant additional improvement of total PDQ-39 score by another 22.9 %. In this group the emotions, stigma and communication subscales improved after the stimulation increase, without further change of UPDRS III. We were able to demonstrate that the increase of stimulation parameters (amplitude) has a potential to improve some non-motor functions and aspects of QoL and thus has an additional effect on quality of life in certain subset of PD patients. The meticulous observation of QoL should be a routine part of assessments before and after the DBS STN surgery, and can even aid during the parameter setting.

Entities:  

Mesh:

Year:  2013        PMID: 23474852     DOI: 10.1007/s00702-013-0990-4

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  21 in total

Review 1.  Selection of stimulus parameters for deep brain stimulation.

Authors:  Alexis M Kuncel; Warren M Grill
Journal:  Clin Neurophysiol       Date:  2004-11       Impact factor: 3.708

Review 2.  Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes.

Authors:  Galit Kleiner-Fisman; Jan Herzog; David N Fisman; Filippo Tamma; Kelly E Lyons; Rajesh Pahwa; Anthony E Lang; Günther Deuschl
Journal:  Mov Disord       Date:  2006-06       Impact factor: 10.338

3.  Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease.

Authors:  Sophie Drapier; Sylvie Raoul; Dominique Drapier; Emmanuelle Leray; François Lallement; Isabelle Rivier; Paul Sauleau; Youen Lajat; Gilles Edan; Marc Vérin
Journal:  J Neurol       Date:  2005-03-23       Impact factor: 4.849

4.  Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safety.

Authors:  Tanya Simuni; Jurg L Jaggi; Heather Mulholland; Howard I Hurtig; Amy Colcher; Andrew D Siderowf; Bernard Ravina; Brett E Skolnick; Reid Goldstein; Matthew B Stern; Gordon H Baltuch
Journal:  J Neurosurg       Date:  2002-04       Impact factor: 5.115

5.  Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.

Authors:  M C Rodriguez-Oroz; J A Obeso; A E Lang; J-L Houeto; P Pollak; S Rehncrona; J Kulisevsky; A Albanese; J Volkmann; M I Hariz; N P Quinn; J D Speelman; J Guridi; I Zamarbide; A Gironell; J Molet; B Pascual-Sedano; B Pidoux; A M Bonnet; Y Agid; J Xie; A-L Benabid; A M Lozano; J Saint-Cyr; L Romito; M F Contarino; M Scerrati; V Fraix; N Van Blercom
Journal:  Brain       Date:  2005-06-23       Impact factor: 13.501

6.  What contributes to quality of life in patients with Parkinson's disease?

Authors:  A Schrag; M Jahanshahi; N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

7.  Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.

Authors:  Kenneth A Follett; Frances M Weaver; Matthew Stern; Kwan Hur; Crystal L Harris; Ping Luo; William J Marks; Johannes Rothlind; Oren Sagher; Claudia Moy; Rajesh Pahwa; Kim Burchiel; Penelope Hogarth; Eugene C Lai; John E Duda; Kathryn Holloway; Ali Samii; Stacy Horn; Jeff M Bronstein; Gatana Stoner; Philip A Starr; Richard Simpson; Gordon Baltuch; Antonio De Salles; Grant D Huang; Domenic J Reda
Journal:  N Engl J Med       Date:  2010-06-03       Impact factor: 91.245

8.  Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial.

Authors:  Adrian Williams; Steven Gill; Thelekat Varma; Crispin Jenkinson; Niall Quinn; Rosalind Mitchell; Richard Scott; Natalie Ives; Caroline Rick; Jane Daniels; Smitaa Patel; Keith Wheatley
Journal:  Lancet Neurol       Date:  2010-04-29       Impact factor: 44.182

9.  Quantitation of non-motor symptoms in Parkinson's disease.

Authors:  K Ray Chaudhuri; P Martinez-Martin
Journal:  Eur J Neurol       Date:  2008-09       Impact factor: 6.089

10.  Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.

Authors:  E A Spottke; J Volkmann; D Lorenz; P Krack; A M Smala; V Sturm; A Gerstner; K Berger; D Hellwig; G Deuschl; H J Freund; W H Oertel; R C Dodel
Journal:  J Neurol       Date:  2002-06       Impact factor: 4.849

View more
  2 in total

1.  Lateral hypothalamic kindling induces manic-like behavior in rats: a novel animal model.

Authors:  Osama A Abulseoud; Ulas M Camsari; Christina L Ruby; Khalid Mohamed; Noha M Abdel Gawad; Aimen Kasasbeh; Mehmet Y Yüksel; Doo-Sup Choi
Journal:  Int J Bipolar Disord       Date:  2014-06-14

2.  Enhancing Quality of Life in Indian Parkinson's Disease Patients with Improved Measurement of Psychological Domains: A Perspective.

Authors:  Ashima Nehra; Priya Sharma; Avneesh Narain; Shivani Sharma; Garima Joshi; Priyanka Bhat; Rajesh Kumar Singh; Roopa Rajan; Vinay Goyal; Achal Kumar Srivastava
Journal:  Ann Indian Acad Neurol       Date:  2021-04-10       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.